Reuters Health Report

Click to View in Browser 04/22/2014 Pfizer agrees to $190 million settlement over generic Neurontin NEW YORK (Reuters) - Pfizer Inc has agreed to pay $190 million to settle a class action lawsuit alleging the pharmaceutical company took steps to delay market entry of generic versions of its epilepsy drug Neurontin, according to court documents filed on Monday. FDA proposes program for fast approval of medical devices (Reuters) - The U.S. Food and Drug Administration proposed on Tuesday a new, more collaborative approach for faster approval of high-risk medical devices intended to treat patients with serious conditions with no other treatment options. Valeant, Ackman offer to buy Botox maker Allergan for $47 billion (Reuters) - Canada's Valeant Pharmaceuticals International Inc said on Tuesday it has partnered with activist investor Bill Ackman in an unsolicited $47 billion bid to buy Botox maker Allergan Inc in a move to eventually become one of the world's five biggest drug companies. U.S. top court asks if Coca-Cola juice label is misleading WASHINGTON (Reuters) - U.S. Supreme Court justices grilled a lawyer for Coca-Cola Co on Monday, asking why a juice label touting the presence of pomegranates and blueberries should not be considered misleading if the drink contained just a trace of the fruits. U.S. court postpones injunction against Medtronic heart valve (Reuters) - A U.S. appeals court on Monday postponed an injunction that would have stopped Medtronic Inc from selling its CoreValve heart valve implant in competition with Edwards Lifesciences Corp's Sapien valve product. False-positive mammograms have limited effect on anxiety NEW YORK (Reuters Health) - Women whose mammograms suggest possible breast cancer that is eventually ruled out experience slightly increased anxiety, but that doesn't necessarily affect their overall health, according to a new study. FDA approves Eli Lilly drug for stomach cancer (Reuters) - U.S. health regulators on Monday approved an Eli Lilly and Co drug to treat advanced stomach cancer and a form of cancer in the area where the esophagus joins the stomach. Improving feelings of control may curb desire to drink NEW YORK (Reuters Health) - The authors of a new study say that manipulating alcohol drinkers' sense of control can counteract the negative feelings that motivate them to drink. AstraZeneca cancer pipeline seen as draw for Pfizer LONDON (Reuters) - Pfizer Inc may come back to bid for British drug company AstraZeneca Plc after its reported 60 billion pound ($101 billion) takeover approach was rejected, since a deal could make sense for the U.S. pharmaceuticals giant as it seeks to build up its cancer franchise. ER trips for kids' pain and coughs often end with codeine NEW YORK (Reuters Health) - Despite recommendations against the use of codeine in children, a new study found many emergency room doctors still give the potentially dangerous opioid to kids, such as for pain and coughs. Related Video Turning smog into jewels - a Dutch designer's solution to Beijing's pollution Titan Aerospace a sky-high platform for Google's internet ambitions The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend